Literature DB >> 19758879

In-laboratory femoral sheath removal after heparin reversal by protamine after percutaneous coronary intervention.

Leif Thuesen1, Henning Rud Andersen, Hans Erik Bøtker, Steen Dalby Kristensen, Lars Romer Krusell, Jens Flensted Lassen.   

Abstract

OBJECTIVE: To evaluate the safety of heparin neutralisation by protamine immediately after PCI.
DESIGN: Retrospective analysis of prospectively registered data.
SETTING: A Danish mono-centre study. PATIENTS: All angina pectoris patients treated with PCI between January 1999 and December 2002. The cohort was divided into two groups. Group I (n=1.129 procedures) were patients admitted January 1999 to December 1999, and group II n=4.193 procedures) were admitted January 1, 2000 to December 31, 2002.
INTERVENTIONS: In group I, the femoral sheath was removed 4 hours after the PCI procedure. In group II, circulating heparin was neutralised by protamine sulphate, and the femoral sheath removed immediately after the procedure. MAIN OUTCOME MEASURES: Rates of puncture site complications, stent thrombosis, non-fatal myocardial infarction and death during admission.
RESULTS: The rates of stent thrombosis, non-fatal myocardial infarction and in-hospital mortality were similar in the two groups. The rate of puncture site complications were 4,7% in group 1 and 2,6% in group 2 (p<0,001).
CONCLUSIONS: Circulating heparin can be safely neutralised by protamine sulphate immediately after PCI.

Entities:  

Year:  2005        PMID: 19758879

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  3 in total

1.  Safety and benefits of protamine administration to revert anticoagulation soon after coronary angioplasty. A meta-analysis.

Authors:  Giuseppe De Luca; Guido Parodi; David Antoniucci
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

2.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy.

Authors:  Daniel M Witt; Robby Nieuwlaat; Nathan P Clark; Jack Ansell; Anne Holbrook; Jane Skov; Nadine Shehab; Juliet Mock; Tarra Myers; Francesco Dentali; Mark A Crowther; Arnav Agarwal; Meha Bhatt; Rasha Khatib; John J Riva; Yuan Zhang; Gordon Guyatt
Journal:  Blood Adv       Date:  2018-11-27

3.  Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy.

Authors:  Guido Parodi; Giuseppe De Luca; Guia Moschi; Benedetta Bellandi; Renato Valenti; Angela Migliorini; Nazario Carrabba; David Antoniucci
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.